- Home
- LGIH vs BLFS Comparison
LGIH vs BLFS Comparison
Compare LGIH & BLFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LGIH
- BLFS
- Stock Information
- Founded
- LGIH 2003
- BLFS 1987
- Country
- LGIH United States
- BLFS United States
- Employees
- LGIH N/A
- BLFS N/A
- Industry
- LGIH Homebuilding
- BLFS Medical/Dental Instruments
- Sector
- LGIH Consumer Discretionary
- BLFS Health Care
- Exchange
- LGIH Nasdaq
- BLFS Nasdaq
- Market Cap
- LGIH 1.3B
- BLFS 1.2B
- IPO Year
- LGIH 2013
- BLFS 1989
- Fundamental
- Price
- LGIH $59.47
- BLFS $24.63
- Analyst Decision
- LGIH Hold
- BLFS Strong Buy
- Analyst Count
- LGIH 4
- BLFS 7
- Target Price
- LGIH $115.00
- BLFS $30.57
- AVG Volume (30 Days)
- LGIH 358.2K
- BLFS 654.8K
- Earning Date
- LGIH 04-29-2025
- BLFS 05-08-2025
- Dividend Yield
- LGIH N/A
- BLFS N/A
- EPS Growth
- LGIH N/A
- BLFS N/A
- EPS
- LGIH 8.30
- BLFS N/A
- Revenue
- LGIH $2,202,598,000.00
- BLFS $82,254,000.00
- Revenue This Year
- LGIH $10.51
- BLFS $20.32
- Revenue Next Year
- LGIH $21.49
- BLFS $19.98
- P/E Ratio
- LGIH $7.30
- BLFS N/A
- Revenue Growth
- LGIH N/A
- BLFS 8.44
- 52 Week Low
- LGIH $53.13
- BLFS $16.10
- 52 Week High
- LGIH $125.83
- BLFS $29.55
- Technical
- Relative Strength Index (RSI)
- LGIH 42.84
- BLFS 54.55
- Support Level
- LGIH $53.13
- BLFS $20.86
- Resistance Level
- LGIH $63.64
- BLFS $24.72
- Average True Range (ATR)
- LGIH 4.49
- BLFS 1.74
- MACD
- LGIH 0.67
- BLFS 0.34
- Stochastic Oscillator
- LGIH 45.47
- BLFS 93.15
About LGIH LGI Homes Inc.
LGI Homes Inc is engaged in the design, construction, and sale of new homes in markets. The company current product offerings include entry-level homes, including both detached homes and townhomes, and move-up homes sold, which are sold under LGI Homes brand, and luxury series homes, which are sold under the Terrata Homes brand. It offers a set number of floor plans in each community with features that include upgrades, such as granite countertops, appliances, and ceramic tile flooring. They have seven operating segments ( Central, Midwest, Southeast, Mid-Atlantic, Northwest, West and Florida divisions) that it aggregates into five qualifying reportable segment. Majority of the revenue is generated from Central division segment.
About BLFS BioLife Solutions Inc.
BioLife Solutions Inc is active in the healthcare segment. The company is engaged in developing, manufacturing, and marketing a portfolio of biopreservation tools and services for cells, tissues, and organs, including clinical grade cell and tissue hypothermic storage and cryopreservation freeze media and a related cloud, hosted biologistics cold chain management application for shippers. The company's product offerings include hypothermic storage and cryopreservation freeze media products for cells, tissues, and organs.